Nancy T. Chang
CIK: 0001135041
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Aug 3, 2026GRTX
Galera Therapeutics, Inc.
Disposition(D)Direct47.4K shares- - Jul 15, 2026WTI
W&T OFFSHORE INC
Sale(S)Direct60K shares at avg. $3.31$199K - Jun 3, 2026WTI
W&T OFFSHORE INC
Award(A)DirectRestricted Stock Units
36K shares- - Jun 3, 2026WTI
W&T OFFSHORE INC
Exercise(M)Direct103.4K shares- - May 22, 2026IMMX
Immix Biopharma, Inc.
Award(A)Direct6.3K shares- - May 15, 2026GRTX
Galera Therapeutics, Inc.
Conversion(C)Direct661.3K shares- - Apr 7, 2026GRTX
Galera Therapeutics, Inc.
Conversion(C)Direct1.2M shares- - Nov 21, 2025IMMX
Immix Biopharma, Inc.
Award(A)DirectStock Option (Right to Buy)
39.6K shares- - Jun 3, 2025WTI
W&T OFFSHORE INC
Exercise(M)Direct73.9K shares- - Jun 3, 2025WTI
W&T OFFSHORE INC
Award(A)DirectRestricted Stock Units
103.4K shares- - Feb 24, 2025GRTX
Galera Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
96K shares- - Dec 30, 2024GRTX
Galera Therapeutics, Inc.
Award(A)DirectSeries B Preferred Stock
1.8K shares- - Dec 30, 2024GRTX
Galera Therapeutics, Inc.
Purchase(P)Direct7.6M shares at avg. $0.07$500K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 3, 2026 |  GRTX Galera Therapeutics, Inc. | Disposition(D) | 47,434 | - | $0 | Direct |
| Jul 15, 2026 |  WTI W&T OFFSHORE INC | Sale(S) | 60,000 | $3.31 | $198,600 | Direct |
| Jun 3, 2026 | WTI W&T OFFSHORE INC | Award(A) Restricted Stock Units | 35,972 | - | - | Direct |
| Jun 3, 2026 | WTI W&T OFFSHORE INC | Exercise(M) | 103,448 | - | $0 | Direct |
| May 22, 2026 |  IMMX Immix Biopharma, Inc. | Award(A) | 6,250 | - | $0 | Direct |
| May 15, 2026 | GRTX Galera Therapeutics, Inc. | Conversion(C) | 661,309 | - | $0 | Direct |
| Apr 7, 2026 | GRTX Galera Therapeutics, Inc. | Conversion(C) | 1,180,611 | - | $0 | Direct |
| Nov 21, 2025 | IMMX Immix Biopharma, Inc. | Award(A) Stock Option (Right to Buy) | 39,643 | - | - | Direct |
| Jun 3, 2025 | WTI W&T OFFSHORE INC | Exercise(M) | 73,892 | - | - | Direct |
| Jun 3, 2025 | WTI W&T OFFSHORE INC | Award(A) Restricted Stock Units | 103,448 | - | - | Direct |
| Feb 24, 2025 | GRTX Galera Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 96,000 | - | - | Direct |
| Dec 30, 2024 | GRTX Galera Therapeutics, Inc. | Award(A) Series B Preferred Stock | 1,842 | - | - | Direct |
| Dec 30, 2024 | GRTX Galera Therapeutics, Inc. | Purchase(P) | 7,644,932 | $0.07 | $499,979 | Direct |
1-13 of 13 transactions
About CHANG NANCY T
CHANG NANCY T (SEC CIK 0001135041) files insider reports with the SEC as Director of Galera Therapeutics, Inc. (GRTX), Director of W&T OFFSHORE INC (WTI) and Director of Immix Biopharma, Inc. (IMMX).
Signal8 holds 11 ownership filings by CHANG NANCY T (2 Form 3, 9 Form 4), filed between Jan 2, 2025 and Aug 5, 2026. Those filings report 13 transactions, from Dec 30, 2024 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on CHANG NANCY T's filings is in MALVERN, PA.
Recent filings by CHANG NANCY T
- Aug 3, 2026: Disposition to issuer transaction of GRTX shares (Form 4, code D).
- Jul 15, 2026: Open-market sale of WTI shares (Form 4, code S).
- Jun 3, 2026: Grant or award of WTI derivative securities (Form 4, code A).
- Jun 3, 2026: Option exercise of WTI shares (Form 4, code M).
- May 22, 2026: Grant or award of IMMX shares (Form 4, code A).
Other insiders filing for Galera Therapeutics, Inc. (GRTX)
- Sorensen Mel, President and CEO
- LOKAY KEVIN G, Director
- Alleva Lawrence M, Director
- Sussman Joel F., Chief Accounting Officer
- FRIEDMAN MICHAEL R., Director
- Emerald Bioventures, LLC, 10% Owner